Clinical Trial Update: Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Aralast NP with antiviral treatment and standard care versus antiviral treatment with standard care in hospitalized COVID-19 pneumonia p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Aralast NP (alpha1-antitrypsin)

Snippet

Sponsor: Blessing Corporate Services, Inc | Conditions: Covid19, Pneumonia, Viral | Phase 3 | Status: WITHDRAWN